Report on DNA Sequencing: Emerging Technologies and Applications

REPORT HIGHLIGHTS

  The global market for sequencing products was nearly $3 billion in 2011, and it is forecast to grow at a compound annual growth rate (CAGR) of 17.5% to reach $6.6 billion by 2016.

 Sequencing instruments and consumables made up the largest market segment in 2011, with revenues of nearly $1.6 billion. BCC expects this market to grow to $2.2 billion by 2016, a CAGR of 7.3%.

 The sequencing services market was $838 million in 2010, which reached nearly $988 million in 2011. Sequencing services comprise the fastest-growing market segment with a 29% CAGR estimated to reach $3.5 billion by 2016. 

 INTRODUCTION  STUDY GOALS AND OBJECTIVES

BCC Research’s goal for this study is to provide a comprehensive analysis of the sequencing industry by examining all parts of the sequencing value chain. This includes sequencing sample preparation reagents and kits, instruments and consumables, bioinformatics and services. BCC Research examined the markets for these products and services for the years 2010, 2011 and 2016.
 
This report’s particular objective is to characterize and quantify the DNA sequencing markets by product type, platform, customer type, value chain position, analysis type and geography.
 
Segments of the sequencing applications market that will provide substantial future growth opportunities for industry participants include consumer and diagnostic , bioinformatics, sequence enrichment, benchtop NGS sequencers and consumables, and emerging sequencing instruments.

This report’s main objective is to present a comprehensive discussion of DNA sequencing technologies, industry structure, key applications, major sequencing initiatives, global markets, patent status and sequencing companies. This discussion will assist life science companies in strategic planning to meet the challenges and opportunities of this dynamic industry.

REASONS FOR DOING THE STUDY

The Human Genome Project (HGP) moved DNA sequencing technology to the forefront of life science research as a genetic analysis tool. The HGP relied heavily on Sanger sequencing by capillary electrophoresis to decipher the DNA sequence of the bases in the human genome. A significant outcome of the HGP was improvements in the efficiency and costs of DNA sequencing. During this time period, the sequencing industry consolidated, resulting in one dominant company, Applied Biosystems (now Life Technologies).
 
Beginning in 2005, new sequencing technologies radically changed the structure of the industry and opened up exciting new market applications. Opportunities emerged in sequencing workflow, instrumentation and services. The new sequencing industry is dynamic, with multiple competitors, technologies and market applications. Based on these market and technology dynamics, it is timely to examine the future DNA sequencing markets.
 
Ongoing advances in nanotechnology, microfluidics, imaging, enzymology and bioinformatics are revolutionizing many life science fields, as well as providing novel platforms for sequencing. At the same time, there is a growing market demand for analyzing the human genome with the goal of understanding how genetic variation relates to disease. The genetic analysis industry seeks to meet these needs with an array of tools, including microarrays, biochips, real-time polymerase chain reaction (RT-PCR) and DNA sequencing instruments.
 
The latest sequencing technologies compete with traditional genetic analysis tools, and this report examines this trend and its significance for companies supplying DNA sequencing products and services.
 
New generations of DNA sequencing technologies will continue to affect the dynamics of this industry and create novel market opportunities. This report analyzes these trends and their impact on the future markets for DNA sequencing products and services.
 
Given the rapid growth of this industry, it is timely to gain an understanding of these technological and competitive forces and their impact on the genetic analysis markets.